Haise Pharmaceuticals: Sodium thiosulfate injection obtains drug registration certificate.

On September 19th, Haichen Pharmaceutical announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Sodium Thiosulfate Injection. This drug is classified as a Category 3 chemical drug, mainly used for cyanide poisoning, and can also be used for arsenic, mercury, lead, bismuth, iodine poisoning. Sodium thiosulfate is considered to be a sulfur donor in the reaction catalyzed by rhodanase, thereby enhancing the endogenous detoxification of cyanide.